Federated Hermes
BNGO icon

Federated Hermes’s Bionano Genomics BNGO Stock Holding History

Federated Hermes’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– -$4 – 2131
2022
Q4 		– Hold
0
– – – 2151
2022
Q3 		– Sell
-1
Closed -$1.32K – 2012
2022
Q2 		$2K Buy
+1
New +$1.03K ﹤0.01% 1966
2019
Q3 		– Sell
-28
Closed -$41K – 2209
2019
Q2 		$41K Hold
28
– – ﹤0.01% 1707
2019
Q1 		$73K Hold
28
– – ﹤0.01% 1620
2018
Q4 		$78K Sell
28
-11,840
-100% -$47.2M ﹤0.01% 1628
2018
Q3 		$56.7M Buy
+11,868
New +$50.6M 0.13% 181

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes's BNGO Position: Q1 2023 in Review

Federated Hermes held its Bionano Genomics (BNGO) position steady in Q1 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2131.

Federated Hermes first reported a position in BNGO in Q3 2018 and has held it in 5 quarters since. The position peaked at $56.7M in Q3 2018. 126 funds tracked by Wall St. Rank hold BNGO as of Q1 2023.

  • Federated Hermes held 0 shares of Bionano Genomics worth $0 as of Q1 2023.
  • Federated Hermes left its Bionano Genomics share count unchanged in Q1 2023.
  • Bionano Genomics made up ﹤0.01% of Federated Hermes's portfolio in Q1 2023, its #2131 holding.
  • Federated Hermes first reported a position in Bionano Genomics in Q3 2018 and has held it in 5 quarters since.
  • Federated Hermes's Bionano Genomics position peaked at $56.7M in Q3 2018.
  • 126 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2023.

Based on Federated Hermes's 13F filing for Q1 2023, filed 8 May 2023.